Pathophysiology, Risk Factors and Management of Chronic Heart Failure, Volume 2

Singh, Ram B., Fedacko, Jan, Hristova, Krasimira

  • 出版商: Academic Press
  • 出版日期: 2024-02-01
  • 售價: $5,880
  • 貴賓價: 9.5$5,586
  • 語言: 英文
  • 頁數: 410
  • 裝訂: Quality Paper - also called trade paper
  • ISBN: 0128229705
  • ISBN-13: 9780128229705
  • 海外代購書籍(需單獨結帳)

相關主題

商品描述

Pathophysiology, Risk factors and Management of Chronic Heart Failure, Volume 2 is the second of two separate but closely related volumes which aim to provide an inclusive overview on Chronic Heart Failure (CHF).This second volume is focused on the therapies of various kinds, management, guidelines and future advances in heart failure. It explains the uncertainties and issues in pharmacological therapies in CHF, along with a number of new treatment options such as gene therapy, cell implantation therapy, invasive and surgical interventions, and non-pharmacological therapies, which would include dietary interventions, holistic approaches, and physical training. It discusses in depth the management of patients with heart failure, and concludes with detailed and updated guidelines from the International College of Cardiology, as well as future research directions and advances.These 2 separate volumes serve as essential references to both researchers and practicing clinicians, proposing novel methods of research by using behavioural and environmental risk factors as intervention agent, as well as discussing deficiency in the present approaches in management of HF and proposing new methods of early diagnosis and therapies for the clinical management of CHF.

商品描述(中文翻譯)

《慢性心臟衰竭的病理生理學、風險因素和管理,第2卷》是兩個獨立但密切相關的卷冊之一,旨在提供對慢性心臟衰竭(CHF)的全面概述。這第二卷專注於各種治療方法、管理、指南和心臟衰竭的未來進展。它解釋了在CHF的藥物治療中的不確定性和問題,以及一些新的治療選項,如基因治療、細胞植入治療、侵入性和手術干預,以及非藥物治療,包括飲食干預、整體療法和體育訓練。它深入討論了心臟衰竭患者的管理,並以國際心臟學院的詳細和最新指南作為結論,以及未來的研究方向和進展。這兩個獨立的卷冊對研究人員和臨床醫生都是必不可少的參考資料,提出了使用行為和環境風險因素作為干預因子的新研究方法,並討論了現有的HF管理方法的不足之處,提出了早期診斷和臨床管理CHF的新方法。